Drug Trial Radar · NCT07451613
Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease
Last checked: Nov 20, 2026Latest source record: Apr 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
21
Planned (sponsor's estimate)
Start
Apr 6, 2026
Primary completion
Jun 2028
Study completion Jan 2031
Sponsor
- Lead sponsor
- Leslie ThompsonAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- California Institute for Regenerative Medicine (CIRM); University of California, Irvine
- First posted
- Mar 5, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this research study is to determine whether an implantation of hNSC-01 is a safe and tolerable study intervention for Huntington's disease. This study is the first time that hNSC-01 is being tested in people.
Conditions
- Huntington Disease
Interventions
hNSC-01Biological
neural stem cell therapy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with treatment-related adverse events as assessed by CTCAE v5.0 after 6 and 12 weeks after dosing.Time frame: Safety is assessed 6 weeks following each surgery for Cohort A and 12 weeks following cohort B-D completion
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of California, Irvine
Irvine, California · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.